APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $260,637 | -66.2% | 2,861 | -74.7% | 0.02% | -39.3% |
| Q3 2022 | $771,000 | +175.4% | 11,293 | +154.7% | 0.03% | +250.0% |
| Q2 2021 | $280,000 | -57.6% | 4,434 | -71.2% | 0.01% | -52.9% |
| Q1 2021 | $660,000 | +411.6% | 15,391 | +289.1% | 0.02% | +142.9% |
| Q2 2020 | $129,000 | +37.2% | 3,956 | +12.8% | 0.01% | +16.7% |
| Q1 2020 | $94,000 | +1466.7% | 3,508 | +1654.0% | 0.01% | – |
| Q4 2019 | $6,000 | -96.2% | 200 | -98.3% | 0.00% | -100.0% |
| Q4 2018 | $156,000 | – | 11,790 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |